Pharma has a lot to be proud of. In the last ten months, the industry has stepped up to deal with the consequences of COVID-19, without neglecting other disease indications. Below, you’ll find a selection of articles that showcase how the industry continues to flourish – from innovation in the ADC sector, to R&D wins in immunology research. What are your predictions for the year ahead? Let us know.

Till next time, Maryam Mahdi, Associate Editor.

Celebrating Great British Pharma
12/22/2020 | Cheryl Teoh
Why the UK can hold its head high in the drive for pharma innovation.
Advancing ADC Development
Can prodrug payloads lead to a new dawn for antibody drug conjugates?
Crafting a Culture of Excellence
01/12/2021 | Maryam Mahdi
Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.
Cell Engineering, Meet Big Data
01/13/2021 | James Strachan
Big Data opens the door to even smarter cell therapies.
White Papers
Exploring the Value of GPC/SEC in Polysaccharide Characterization

The properties of polymeric excipients can directly affect the clinical efficacy, safety, and quality of a finished pharmaceutical product and are routinely identified as critical quality attributes (CQAs). Read More.

Toothpaste identification by FingerPrint

This application note shows that the Epsilon 4 is fully capable of identifying small differences in materials. The finger printing technique is applicable to all materials including liquids, powders and solids. Read More.

Product Profile
OneXpress™ Solution for Accelerating Development to Commercialization

Catalent’s new OneXpress™ solution combines phase-appropriate scale and technologies with expertise across diverse dose forms to accelerate a program’s development to commercialization. Read more

Special Promotions
Today: Product Launch - Expand Your Process with Ease

Efficient scale-up is one of the major hurdles in modern biotechnology. Join Eppendorf today at their event platform “Planet of Knowledge" when they reveal their newest bioprocess control system.

We Need to Talk About Cell and Gene Therapy

Experts explain why the advanced therapy field must progress with the needs of the patient – as defined by the patient – in mind in The Medicine Maker Cell and Gene Therapy Supplement.

The Power List 2021 - Your last chance to nominate!

The Power List is a celebration of the most inspirational professionals working in the pharma industry to develop and manufacture ground-breaking new medicines. We want you to tell us who you think should be included on this prestigious list. Nominations close January 25, 2021. Nominate for 2021!

Facing the COVID-19 Crisis: Leadership and the Future of Pharma

We brought together an expert panel of Power List winners to discuss the impact of COVID-19 on the industry, the challenges of leadership during the pandemic, and the lessons the pharma industry must learn as a whole from the crisis. Hear what they have to say here

Help us measure “Pandemic Impact” in Biopharma for a chance to win $100!

Take the “Pandemic Impact: Biopharma Trends 2021 Survey” now and you could win a $100 Amazon voucher (or a charitable donation, if preferred). Start Survey

Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.

Find out more